|
|
Article: Galileo Genomics Announces $16.5-million in Equity Funding.
- Article from:
- PR Newswire
- Article date:
- October 10, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, Oct. 10 /PRNewswire/
- Galileo Genomics Inc., a Montreal-based genomics company, announced today it has secured $16.5-million in equity funding. The lead investor, Investissement Desjardins of Montreal, was joined by other major investors, BTF of the Netherlands, MVI of Europe and HBM BioVentures of Switzerland.
Galileo will use these funds to search for genes associated with 25 common and economically important diseases. The research will be carried out with approximately 50,000 members of the Quebec population. The company will also use some of the equity funding to further develop its technology platform for the discovery of disease genes, ...